ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2601

Improving Delivery of Care for JIA Across a Multi-Center Network Using a Shared Data Registry and Quality Improvement Science: The Pediatric Rheumatology Care and Outcomes Improvement Network

Catherine A. Bingham1, Lynn M. Darbie2, Keith Marsolo3, Jennifer E. Weiss4, Stacy P. Ardoin5, Ronald Laxer6, D. J. Lovell7, Murray H. Passo8, Sheetal Vora9, Beth S. Gottlieb10, Timothy Beukelman11, Nancy Griffin2, Jason A. Stock12, Michael L. Miller13, Karen Onel14, Tova Ronis15, Peter Margolis16 and Esi M. Morgan DeWitt17, 1Pediatric Rheumatology, Penn State Hershey Children's Hospital, Hershey, PA, 2James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Division of Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH, 4Pediatric Rheumatology, Hackensack University Medical Center, Hackensack, NJ, 5Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, 6Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 7Cincinnati Children's Hospital, Cincinnati, OH, 8Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, 9Pediatric Rheumatology, Medical College of Wisconsin, Milwaukee, WI, 10Pediatric Rheumatology, Cohen Children's Medical Center of New York, New Hyde Park, NY, 11Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 12Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 13Rheumatology, Childrens Memorial Hospital, Chicago, IL, 14Pediatric Rheumatology, University of Chicago, Chicago, IL, 15Pediatric Rheumatology, Stanford University Hospital, Palo Alto, CA, 16Clinical Effectiveness, Cincinnati Children's Hospital, Cincinnati, OH, 17Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA), outcome measures and quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Quality Measures and Innovations in Practice Management and Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose: The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a quality improvement (QI) multi-center “learning network” that performs QI and research while tracking progress through data collection, analysis, and display.  The mission is to optimize processes of care and improve outcomes in juvenile idiopathic arthritis (JIA). PR-COIN began operating in the spring of 2011 and currently has 12 participating sites in the United States and Canada. This is the first report of our data.

Methods: Our approach is based on the Institute for Healthcare Improvement Breakthrough Series Collaborative Model with planned interventions to improve outcomes based on the Chronic Illness Care Model. Conference calls, web-based information exchange, and face-to-face learning sessions are forums for teams to gain expertise in QI science, share knowledge, and develop new strategies to improve care. Teams conduct “Plan-Do-Study-Act” cycles to enact improvement and submit data and progress reports monthly. After informed consent/assent is obtained, site patient data are entered into the ACR’s Rheumatology Clinical Registry in order to track progress of the network over time. Design of data collection forms allows assessment of performance on published proposed JIA quality measures (QM) (Arthritis Care Res 2011 Jan;63(1):10-6) and monitoring of clinical outcomes. 13 processes of care QMs and 4 clinical outcomes QMs are tracked.  Site specific and aggregate data are analyzed monthly and provided with transparency as feedback to the sites.  Benchmarking is possible through analysis of the data submitted by participating practices, and shared information can accelerate improvement throughout the network.

Results: As of May 2012, 516 patients from 7 sites have been entered into the registry for longitudinal assessment.  Performance exceeded goal on 2 process of care QM: measurement at clinic visits of complete joint count (mean 100%, goal 90%) and pain assessment (mean 96%, goal 90).  Examples of process QM requiring improvement work include: uveitis screening per Heiligenhaus guidelines (mean 72%, goal 90%); toxicity labs for DMARDs per guidelines (mean 72%, goal 90%); measurement every 180 days of: functional ability (mean 81%, goal 90%) , and HRQOL  (mean 3%, goal 90%). Our baseline outcome measures showed: 77% of patients have a pain score < 3; 58% patients have an optimal CHAQ score of 0; and 33% of patients on JIA medication and 60% patients off JIA medication could be defined as having clinical inactive disease.

Conclusion: PR-COIN is a growing international QI learning network. Our baseline data demonstrate mixed performance on measures of processes of care. As we reach target performance goals for our measures over time, we will continue to raise the bar for performance. The next phase of our project is to use interventions including implementation of an already developed population management tool, creation of a pre-visit planning tool to facilitate measurable improvement in meeting benchmarks for process of care, and orchestrated testing of which QI interventions most positively impact clinical outcomes.


Disclosure:

C. A. Bingham,
None;

L. M. Darbie,
None;

K. Marsolo,
None;

J. E. Weiss,
None;

S. P. Ardoin,
None;

R. Laxer,

Novartis Pharmaceutical Corporation,

2;

D. J. Lovell,

National Institutes of Health,

2,

Astra-Zeneca, Centocor, Wyeth, Amgen, BMS, Abbott, Pfizer, Regeneron, Hoffmal-La Roche, Novartis, UCB, Xoma,

5,

Arthritis and Rheumatism,

,

Genentech,,

8,

Forest Research,

;

M. H. Passo,
None;

S. Vora,
None;

B. S. Gottlieb,

Pfizer Inc,

5;

T. Beukelman,

Pfizer Inc,

2,

Novartis Pharmaceutical Corporation,

5,

Genentech and Biogen IDEC Inc.,

5;

N. Griffin,
None;

J. A. Stock,
None;

M. L. Miller,
None;

K. Onel,
None;

T. Ronis,
None;

P. Margolis,
None;

E. M. Morgan DeWitt,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-delivery-of-care-for-jia-across-a-multi-center-network-using-a-shared-data-registry-and-quality-improvement-science-the-pediatric-rheumatology-care-and-outcomes-improvement-network/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology